Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients

ConditionSquamous Cell Carcinoma of the Head and Neck

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain

About this trial

The investigators will collect plasma samples at baseline, during treatment, and at progression.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients treated with radiation therapy and cetuximab according to Bonner et al

patients treated with cetuximab in combination with chemotherapy according to Vermorken et al.

patients treated with a molecular targeted agent as a part of a clinical study

Disqualifiers

patients with another type of head and neck cancer

patients non treated with targeted therapies

Trial population

PATIENTS TREATED WITH MOLECULAR TARGETED THERAPIES FOR SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Plasma samples
Other intervention
Plasma samples at baseline (and one whole blood sample) and at every radiological evaluations

Treatment groups

400 Participants

are divided into 1 treatment group

Group A: No treatment1 intervention

Trial outcomes

Primary outcomes

Prospective storage of plasma samples of patients treated with cetuximab or other targeted agents

All the analyses will be done when we have enough of collected samples

Time frame

one year after the collection

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Lead sponsor

Source ClinicalTrials.gov

Apply now